|
|
| Achieve Higher Targeted Concentrations | White Paper | MilliporeSigma | Single-pass TFF streamlines downstream processing by reducing footprint, shear exposure, and hold-up volumes. Learn how this approach is advancing efficiency across therapeutic and vaccine production. |
|
|
| Your Biosimilar, Your Journey | Infographic | Cytiva | With many blockbuster drug patents set to expire by 2030, the market is ripe for biosimilar developers to stake their claim. To succeed, they must be strategic and compliant. |
|
|
|
|
By Jeff Buguliskis, PhD, Deputy Chief Editor, Outsourced Pharma | Capacity isn’t the choke point—capability is; this piece ranks nine fast-growing outsourcing segments and shows sponsors how to win by locking in modality-proven partners early. | |
|
|
|
Paul Gerst, Lina Niu, and Jennifer L. Brown — Pfizer | The company developed a novel approach to address the historic lack of stability testing for underserved parts of the world, near the equator. | |
|
|
